The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
The challenge of biosimilars
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioequivalence and the immunogenicity of biopharmaceuticals
Schellekens, H. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd818 · Cited by 534
Pure Red-Cell Aplasia and Epoetin Therapy
Bennett, C. L., Luminari, S., Nissenson, A. R., Tallman, M. S., Klinge, S. A., McWilliams, N., McKoy, J. M., Kim, B., Lyons, E. A., Trifilio, S. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040528 · Cited by 437
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update
Bokemeyer, C., Aapro, M. S., Courdi, A., Foubert, J., Link, H., Österborg, A., Repetto, L., & Soubeyran, P. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.10.014 · Cited by 403
Antonelli, G., Currenti, M., Turriziani, O., & Dianzani, F. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.4.882 · Cited by 204
Summary of Product Characteristics
Stolerman, I. P., & Price, L. H. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_200037 · Cited by 165
Hörl, W. H. (2013) · Drugs · doi:10.1007/s40265-012-0002-2 · Cited by 134
Spleen enlargement in healthy donors during G–CSF mobilization of PBPCs
Platzbecker, U., Prange‐Krex, G., Bornhäuser, M., Koch, R., Soucek, S., Aikele, P., Haack, A., Haag, C., Schuler, U. S., Berndt, A., et al. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41020184.x · Cited by 120
The role of glycosylation in protein antigenic properties
Lisowska, E. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8437-3 · Cited by 119
Deicher, R., & rl, W. H. H. (2004) · Drugs · doi:10.2165/00003495-200464050-00004 · Cited by 104
Keynote Lecture: Erythropoietin and systemic hypertension
Maschio, G. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.supp2.74 · Cited by 85
Cited by
Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
Pierpont, T. M., Limper, C. B., & Richards, K. L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00163 · Cited by 374
G-CSF and GM-CSF in Neutropenia
Mehta, H. M., Malandra, M., & Corey, S. J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500861 · Cited by 363
Biosimilars: the science of extrapolation
Weise, M., Kurki, P., Wolff-Holz, E., Bielsky, M.-C., & Schneider, C. K. (2014) · Blood · doi:10.1182/blood-2014-06-583617 · Cited by 307
Sozzani, S., Abbracchio, M. P., Annese, V., Danese, S., De Pità, O., De Sarro, G., Maione, S., Olivieri, I., Parodi, A., & Sarzi-Puttini, P. (2014) · Autoimmunity · doi:10.3109/08916934.2014.897333 · Cited by 22
Demir, F., Albarri, R., & Unal, D. O. (2024) · Current Pharmaceutical Analysis · doi:10.2174/0115734129317408240903150800 · Cited by 3
Metadata
- Authors
- Mellstedt, H., Niederwieser, D., & Ludwig, H.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 19
- Issue
- 3
- Pages
- 411-419
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2119740605
- Cited by
- 271
- References
- 17
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The challenge of biosimilars. https://app.cochat.ai/papers/10.1093/annonc/mdm345
- The paper
- Mellstedt, H., Niederwieser, D., & Ludwig, H. (2008). The challenge of biosimilars. Annals of Oncology. https://doi.org/10.1093/annonc/mdm345
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.